Parabilis Heads Biotech Fundraising Frenzy With $305M to Advance Cancer Drug

A bevy of other companies also brought in money on Thursday, including Alveus Therapeutics, Diagonal Therapeutics, EpiBiologics, Beacon Therapeutics and Protege.